Cancer Complications (17)

Doctor zhou

Excessive Immune Reactions Caused by Ipilimumab

Ipilimumab, also known as Y-drug or anti-CTLA4 monoclonal antibody, is a recombinant humanized monoclonal antibody developed by Bristol-Myers Squibb that binds to cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4). Since March 25, 2011, when the US FDA approved Yervoy (3 mg/kg) monotherapy for unresectable or metastatic melanoma, more…

Continue reading...
Doctor zhou

Exploring TCM Approaches to Bleeding in Cancer Patients

Cancer patients frequently develop bleeding complications, such as gastric bleeding in gastric cancer patients, bloody stools in colorectal cancer patients or those with radiation enteritis, vaginal bleeding in cervical and vaginal cancer patients, hemoptysis in lung or laryngeal cancer patients, hematuria in kidney and bladder…

Continue reading...